NSC |
Compound |
Enrichment |
Correlation |
NSC 679516 |
Null |
0.00701295499506013 |
0.24882674 |
NSC 685964 |
Null |
0.00701295499506013 |
0.07531587 |
NSC 686551 |
Null |
0.00701295499506013 |
0.21443925 |
NSC 6926 |
Null |
0.00701295499506013 |
0.40366519 |
NSC 715407 |
Null |
0.00701295499506013 |
0.27086645 |
NSC 719667 |
7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one |
0.00701295499506023 |
0.29301584 |
NSC 725098 |
Null |
0.00701295499506023 |
0.24704772 |
NSC 726217 |
Combretastatin A4-analogue |
0.00701295499506023 |
0.26890307 |
NSC 732962 |
5-amino-4-(1,3-benzothiazol-2-yl)-1-(2-chloro-5-trifluoromet hylphenyl)-2,3-dihydro-1H-3-pyrrolone |
0.00701295499506023 |
0.44497757 |
NSC 743433 |
8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one |
0.00701295499506023 |
0.27517025 |